2-styryl-pyridines and 2-(3,4-dihydro-naphthalen-2-yl)-pyridines as potent NR1/2B subtype selective NMDA receptor antagonists

被引:4
作者
Buettelmann, B [1 ]
Alanine, A
Bourson, A
Gill, R
Heitz, MP
Mutel, V
Pinard, E
Trube, G
Wyler, R
机构
[1] F Hoffmann La Roche Ltd, Div Pharma, Discovery Chem, CH-4070 Basel, Switzerland
[2] F Hoffmann La Roche Ltd, Div Pharma, Preclin CNS Res, CH-4070 Basel, Switzerland
关键词
neurodegeneration; NMDA; NR1/2B antagonists; structure-activity relationship;
D O I
10.2533/000942904777677579
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A series of 2-styryl-pyridines and 2-(3,4-dihydro-naphthalen-2-yl)-pyridines was prepared and evaluated as NR1/2B subtype selective NMDA receptor antagonists. The SAR developed in this series resulted in the discovery of high affinity antagonists that are selective (vs. alpha(1) and M-1 receptors) and are active in vivo.
引用
收藏
页码:630 / 633
页数:4
相关论文
共 22 条
[1]   SYNTHESIS OF BIOLOGICAL MARKERS IN FOSSIL-FUELS .2. SYNTHESIS AND C-13 NMR-STUDIES OF SUBSTITUTED INDANS AND TETRALINS [J].
ADAMCZYK, M ;
WATT, DS ;
NETZEL, DA .
JOURNAL OF ORGANIC CHEMISTRY, 1984, 49 (22) :4226-4237
[2]  
Avdeef A., 1993, APPL THEORY GUIDE PH
[3]   Correlation between 5-HT7 receptor affinity and protection against sound-induced seizures in DBA/2J mice [J].
Bourson, A ;
Kapps, V ;
Zwingelstein, C ;
Rudler, A ;
Boess, FG ;
Sleight, AJ .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 356 (06) :820-826
[4]   4-(3,4-Dihydro-1H-isoquinolin-2yl)-pyridines and 4-(3,4-dihydro-1H-isoquinolin-2-yl)-quinolines as potent NR1/2B subtype selective NMDA receptor antagonists [J].
Büttelmann, B ;
Alanine, A ;
Bourson, A ;
Gill, R ;
Heitz, MP ;
Mutel, V ;
Pinard, E ;
Trube, G ;
Wyler, R .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (10) :1759-1762
[5]   2-(3,4-dihydro-1H-isoquinolin-2yl)-pyridin as a novel class of NR1/2B subtype selective NMDA receptor antagonists [J].
Büttelmann, B ;
Alanine, A ;
Bourson, A ;
Gill, R ;
Heitz, MP ;
Mutel, V ;
Pinard, E ;
Trube, G ;
Wyler, R .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (05) :829-832
[6]  
Chazot P L, 2000, Curr Opin Investig Drugs, V1, P370
[7]  
Chenard BL, 1999, CURR PHARM DESIGN, V5, P381
[8]  
FISCHER G, 1996, NEUR ANN M NOV 16 21
[9]  
Gill R., 1999, CURR OPIN CARDIOVASC, V1, P576
[10]   BINDING CHARACTERISTICS OF PRAZOSIN-H-3 TO RAT-BRAIN ALPHA-ADRENERGIC RECEPTORS [J].
GREENGRASS, P ;
BREMNER, R .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1979, 55 (03) :323-326